aftermathman
06-19-2007, 03:06 AM
didn't exactly get star billing at the latest Bayer Investor day but two key messages :
i) It survived a rigorous pipeline cull.
ii) It is expected to enter P3 in 2008 and the market in 2011.
Go Spheramine.
Neil.
i) It survived a rigorous pipeline cull.
ii) It is expected to enter P3 in 2008 and the market in 2011.
Go Spheramine.
Neil.